Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Lapatanib
Lapatanib
231277-92-2
|
581.058
|
5.965
Lapatinib is a 4-anilinoquinazoline kinase inhibitor of the intracellular tyrosine kinase domains of both epidermal growth factor receptor (HER1/EGFR/ERBB1) and human epidermal growth factor receptor type 2 (HER2/ERBB2). Lapatinib is an anti-cancer drug, used for the treatment for solid tumours such as breast and lung cancer.
GW-572016 | LAP | Lapatinib | apatinib | lapatanib | tykerb | tyverb
Lapatinib is a 4-anilinoquinazoline kinase inhibitor of the intracellular tyrosine kinase domains of both epidermal growth factor receptor (HER1/EGFR/ERBB1) and human epidermal growth factor receptor type 2 (HER2/ERBB2). Lapatinib is an anti-cancer drug, used for the treatment for solid tumours such as breast and lung cancer.
GW-572016 | LAP | Lapatinib | apatinib | lapatanib | tykerb | tyverb
$19/5 mg
(EBC)
1
CAS:388082-78-8
0
CAS:1187538-35-7
0
CAS:231277-92-2
0
We provide 0 compound for Lapatanib